RITUXIMAB AND HYALURONIDASE

RITUXIMAB AND HYALURONIDASE was reported 453 times

These side effects are most commonly reported by patients taking RITUXIMAB AND HYALURONIDASE:

# Side effect Count
0 NO ADVERSE EVENT 88
1 OFF LABEL USE 82
2 RASH 50
3 FATIGUE 36
4 NAUSEA 35
5 PAIN 33
6 HEADACHE 28
7 DIZZINESS 27
8 PNEUMONIA 27
9 DYSPNOEA 26
10 DIARRHOEA 25
11 INTENTIONAL PRODUCT USE ISSUE 25
12 MALAISE 24
13 VISUAL IMPAIRMENT 24
14 PRURITUS 23
15 ABDOMINAL PAIN UPPER 22
16 DECREASED APPETITE 22
17 ERYTHEMA 22
18 SWELLING 22
19 VOMITING 22
20 ABDOMINAL PAIN 21
21 HYPERTENSION 21
22 INFUSION RELATED REACTION 21
23 PYREXIA 21
24 CONTUSION 20
25 MIGRAINE 20
26 ANXIETY 19
27 DEATH 19
28 DRUG HYPERSENSITIVITY 19
29 PANCREATITIS 19
30 ABDOMINAL DISCOMFORT 18
31 ARTHRALGIA 18
32 BREAST CANCER STAGE III 18
33 EAR INFECTION 18
34 FEELING HOT 18
35 HYPERSENSITIVITY 18
36 LARYNGITIS 18
37 NASOPHARYNGITIS 18
38 OSTEOPOROSIS 18
39 WEIGHT DECREASED 18
40 CONFUSIONAL STATE 17
41 DISCOMFORT 17
42 DUODENAL ULCER PERFORATION 17
43 FOLLICULITIS 17
44 FREQUENT BOWEL MOVEMENTS 17
45 HELICOBACTER INFECTION 17
46 HYPOAESTHESIA 17
47 ILL-DEFINED DISORDER 17
48 INFECTION 17
49 INSOMNIA 17
50 PERICARDITIS 17
51 PERIPHERAL SWELLING 17
52 PORPHYRIA ACUTE 17
53 PSORIATIC ARTHROPATHY 17
54 SINUSITIS 17
55 STOMATITIS 17
56 URTICARIA 17
57 WHITE BLOOD CELL COUNT INCREASED 17
58 ARTHRITIS 16
59 ASTHENIA 16
60 BONE EROSION 16
61 DEEP VEIN THROMBOSIS POSTOPERATIVE 16
62 DEPRESSION 16
63 DYSPEPSIA 16
64 EXOSTOSIS 16
65 FOOT DEFORMITY 16
66 GASTROINTESTINAL DISORDER 16
67 INJECTION SITE ERYTHEMA 16
68 INJECTION SITE PAIN 16
69 LOWER LIMB FRACTURE 16
70 OEDEMA PERIPHERAL 16
71 PERIPHERAL VENOUS DISEASE 16
72 RECTAL HAEMORRHAGE 16
73 RHEUMATOID ARTHRITIS 16
74 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 16
75 SYSTEMIC LUPUS ERYTHEMATOSUS 16
76 TYPE 2 DIABETES MELLITUS 16
77 ALOPECIA 15
78 ASTHMA 15
79 BURSITIS 15
80 CHEST PAIN 15
81 CONDITION AGGRAVATED 15
82 CROHN^S DISEASE 15
83 HEPATIC CIRRHOSIS 15
84 HEPATIC ENZYME INCREASED 15
85 HYPERCHOLESTEROLAEMIA 15
86 JOINT RANGE OF MOTION DECREASED 15
87 LABORATORY TEST ABNORMAL 15
88 MEMORY IMPAIRMENT 15
89 MUSCLE SPASMS 15
90 OSTEOARTHRITIS 15
91 PARAESTHESIA 15
92 PRODUCT STORAGE ERROR 15
93 PULMONARY FIBROSIS 15
94 RETINITIS 15
95 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 14
96 ARTHROPATHY 14
97 BLISTER 14
98 DISEASE PROGRESSION 14
99 DRUG INEFFECTIVE 14
100 GAIT DISTURBANCE 14
101 GENERAL PHYSICAL HEALTH DETERIORATION 14
102 GLOSSODYNIA 14
103 HAND DEFORMITY 14
104 INFLAMMATION 14
105 INJURY 14
106 LIVER DISORDER 14
107 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14
108 LOWER RESPIRATORY TRACT INFECTION 14
109 LUNG DISORDER 14
110 MATERNAL EXPOSURE DURING PREGNANCY 14
111 MOBILITY DECREASED 14
112 MUSCULAR WEAKNESS 14
113 NIGHT SWEATS 14
114 OEDEMA 14
115 PEMPHIGUS 14
116 WEIGHT INCREASED 14
117 WHEEZING 14
118 WOUND 14
119 WOUND INFECTION 14
120 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13
121 AMNESIA 13
122 AUTOIMMUNE DISORDER 13
123 BLOOD CHOLESTEROL INCREASED 13
124 COLITIS ULCERATIVE 13
125 DELIRIUM 13
126 DISLOCATION OF VERTEBRA 13
127 DRY MOUTH 13
128 FACET JOINT SYNDROME 13
129 FIBROMYALGIA 13
130 GRIP STRENGTH 13
131 GRIP STRENGTH DECREASED 13
132 HIP ARTHROPLASTY 13
133 IMPAIRED HEALING 13
134 INTERCEPTED PRODUCT STORAGE ERROR 13
135 IRRITABLE BOWEL SYNDROME 13
136 JOINT SWELLING 13
137 LIP DRY 13
138 LIVER INJURY 13
139 LUPUS VULGARIS 13
140 LUPUS-LIKE SYNDROME 13
141 MATERNAL EXPOSURE TIMING UNSPECIFIED 13
142 MUSCLE INJURY 13
143 MUSCULOSKELETAL PAIN 13
144 MUSCULOSKELETAL STIFFNESS 13
145 OBESITY 13
146 RHEUMATIC FEVER 13
147 RHEUMATOID FACTOR POSITIVE 13
148 ROAD TRAFFIC ACCIDENT 13
149 SCIATICA 13
150 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13
151 SWOLLEN JOINT COUNT INCREASED 13
152 SYNOVITIS 13
153 WALKING AID USER 13
154 X-RAY ABNORMAL 13
155 C-REACTIVE PROTEIN ABNORMAL 12
156 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 12
157 KNEE ARTHROPLASTY 12
158 SWOLLEN JOINT COUNT 12
159 CHILLS 11
160 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11
161 WEIGHT FLUCTUATION 11
162 NEOPLASM PROGRESSION 10
163 PRODUCT USE IN UNAPPROVED INDICATION 10
164 COUGH 8
165 INJECTION SITE REACTION 8
166 DRUG INTOLERANCE 7
167 NEUTROPENIA 7
168 PAIN IN EXTREMITY 7
169 CELLULITIS 6
170 HYPOTENSION 6
171 MALIGNANT NEOPLASM PROGRESSION 6
172 PLATELET COUNT DECREASED 6
173 ADVERSE DRUG REACTION 5
174 ADVERSE EVENT 5
175 FLUSHING 5
176 GASTROOESOPHAGEAL REFLUX DISEASE 5
177 HYPERHIDROSIS 5
178 INFUSION SITE REACTION 5
179 INJECTION SITE RASH 5
180 JOINT STIFFNESS 5
181 LOSS OF CONSCIOUSNESS 5
182 NEUROPATHY PERIPHERAL 5
183 SLEEP DISORDER 5
184 TREATMENT NONCOMPLIANCE 5
185 URINARY TRACT INFECTION 5
186 VISION BLURRED 5
187 ABDOMINAL DISTENSION 4
188 BACK INJURY 4
189 BLEPHAROSPASM 4
190 C-REACTIVE PROTEIN INCREASED 4
191 CHEST DISCOMFORT 4
192 CONTRAINDICATED PRODUCT ADMINISTERED 4
193 EPILEPSY 4
194 FALL 4
195 HOSPITALISATION 4
196 IMMUNODEFICIENCY 4
197 INJECTION SITE DISCOLOURATION 4
198 INJECTION SITE DISCOMFORT 4
199 INJECTION SITE WARMTH 4
200 INTERCEPTED MEDICATION ERROR 4
201 JOINT DISLOCATION 4
202 MYALGIA 4
203 NECK PAIN 4
204 ONYCHOMADESIS 4
205 PREGNANCY 4
206 PRESCRIBED OVERDOSE 4
207 PRESCRIBED UNDERDOSE 4
208 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4
209 RESPIRATORY DISORDER 4
210 SKIN EXFOLIATION 4
211 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4
212 SUSPECTED OFF LABEL USE 4
213 THERAPEUTIC PRODUCT EFFECT DECREASED 4
214 THERAPY NON-RESPONDER 4
215 TREATMENT FAILURE 4
216 ANAPHYLACTIC REACTION 3
217 BACK PAIN 3
218 COELIAC DISEASE 3
219 CONSTIPATION 3
220 DRUG TOLERANCE DECREASED 3
221 DRUG-INDUCED LIVER INJURY 3
222 FEELING COLD 3
223 HAEMOGLOBIN INCREASED 3
224 HERPES ZOSTER 3
225 HYPOKALAEMIA 3
226 INCORRECT ROUTE OF DRUG ADMINISTRATION 3
227 INFLAMMATORY BOWEL DISEASE 3
228 INFUSION SITE ERYTHEMA 3
229 INFUSION SITE PRURITUS 3
230 LYMPHOMA 3
231 MASS 3
232 MEDICATION ERROR 3
233 MYOSITIS 3
234 NEUTROPHIL COUNT DECREASED 3
235 PRODUCT DOSE OMISSION ISSUE 3
236 PRODUCT USE ISSUE 3
237 PUSTULAR PSORIASIS 3
238 SKIN WARM 3
239 THROAT IRRITATION 3
240 THROMBOCYTOPENIA 3
241 AGEUSIA 2
242 ANAEMIA 2
243 ANGIOEDEMA 2
244 ANOSMIA 2
245 ATRIAL FIBRILLATION 2
246 BLOOD CREATININE INCREASED 2
247 BLOOD PRESSURE INCREASED 2
248 BLOOD PRESSURE SYSTOLIC INCREASED 2
249 BONE PAIN 2
250 BRONCHITIS 2
251 BURNING SENSATION 2
252 CARDIAC DISORDER 2
253 CATARACT 2
254 CHRONIC LYMPHOCYTIC LEUKAEMIA 2
255 COVID-19 2
256 DIPLOPIA 2
257 EAR PAIN 2
258 EAR PRURITUS 2
259 EPISTAXIS 2
260 EYE PAIN 2
261 EYE SWELLING 2
262 FEBRILE NEUTROPENIA 2
263 FEELING ABNORMAL 2
264 GAIT INABILITY 2
265 GENERALISED ERYTHEMA 2
266 HAEMATOMA 2
267 HAEMOGLOBIN DECREASED 2
268 HEART RATE DECREASED 2
269 HOT FLUSH 2
270 HYPERACUSIS 2
271 HYPOGAMMAGLOBULINAEMIA 2
272 HYPOPHAGIA 2
273 ILLNESS 2
274 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
275 INFLUENZA 2
276 INFLUENZA LIKE ILLNESS 2
277 INFUSION SITE IRRITATION 2
278 INFUSION SITE SWELLING 2
279 INJECTION SITE HAEMORRHAGE 2
280 INJECTION SITE INDURATION 2
281 INJECTION SITE MASS 2
282 INJECTION SITE SWELLING 2
283 LIVER FUNCTION TEST INCREASED 2
284 LOWER RESPIRATORY TRACT CONGESTION 2
285 MENSTRUATION IRREGULAR 2
286 NEOPLASM MALIGNANT 2
287 NERVOUSNESS 2
288 OROPHARYNGEAL DISCOMFORT 2
289 PAIN IN JAW 2
290 PALPITATIONS 2
291 PANCYTOPENIA 2
292 PERFORMANCE STATUS DECREASED 2
293 PHOTOPHOBIA 2
294 PNEUMONIA VIRAL 2
295 PRODUCT PREPARATION ERROR 2
296 PRODUCT PRESCRIBING ERROR 2
297 PRODUCT QUALITY ISSUE 2
298 PRODUCT TEMPERATURE EXCURSION ISSUE 2
299 PRODUCTIVE COUGH 2
300 RASH ERYTHEMATOUS 2
301 RASH PRURITIC 2
302 RENAL FAILURE 2
303 SENSORY DISTURBANCE 2
304 SINUS CONGESTION 2
305 SKIN DISORDER 2
306 SKIN REACTION 2
307 SOMNOLENCE 2
308 SWELLING FACE 2
309 SYNCOPE 2
310 TACHYCARDIA 2
311 TREMOR 2
312 UNEVALUABLE EVENT 2
313 VERTIGO 2
314 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2
315 ABDOMINAL INJURY 1
316 ABDOMINAL TENDERNESS 1
317 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1
318 ALLERGY TO ARTHROPOD STING 1
319 ALLERGY TO CHEMICALS 1
320 ANAEMIA OF CHRONIC DISEASE 1
321 ANAL INCONTINENCE 1
322 ANAPHYLACTIC SHOCK 1
323 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 1
324 AORTIC DISORDER 1
325 AORTIC VALVE CALCIFICATION 1
326 AORTIC VALVE INCOMPETENCE 1
327 ASTHMA EXERCISE INDUCED 1
328 ATELECTASIS 1
329 B-LYMPHOCYTE COUNT INCREASED 1
330 BALANCE DISORDER 1
331 BASOPHILIA 1
332 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1
333 BLOOD COUNT ABNORMAL 1
334 BLOOD GLUCOSE ABNORMAL 1
335 BLOOD GLUCOSE INCREASED 1
336 BLOOD PRESSURE DECREASED 1
337 BLOOD PRESSURE FLUCTUATION 1
338 BLOOD VISCOSITY DECREASED 1
339 BODY TEMPERATURE FLUCTUATION 1
340 BONE SWELLING 1
341 BRAIN FOG 1
342 BRAIN NEOPLASM 1
343 BREAST CANCER 1
344 BREAST CANCER STAGE II 1
345 BREAST CYST 1
346 BRONCHIECTASIS 1
347 C-REACTIVE PROTEIN 1
348 CARDIOMEGALY 1
349 CARDIOMYOPATHY 1
350 CARPAL TUNNEL SYNDROME 1
351 CATHETER SITE HAEMORRHAGE 1
352 CEREBROVASCULAR ACCIDENT 1
353 CERVICAL RADICULOPATHY 1
354 CHRONIC GASTRITIS 1
355 CLOSTRIDIUM DIFFICILE INFECTION 1
356 COGNITIVE DISORDER 1
357 CYST 1
358 CYSTITIS 1
359 CYTOPENIA 1
360 DEMENTIA ALZHEIMER^S TYPE 1
361 DERMATITIS CONTACT 1
362 DEVICE DISLOCATION 1
363 DEVICE INFUSION ISSUE 1
364 DEVICE OCCLUSION 1
365 DISABILITY 1
366 DIVERTICULUM 1
367 DRUG DOSE OMISSION 1
368 DRUG ERUPTION 1
369 DRUG INTERACTION 1
370 DUODENAL ULCER 1
371 DYSPHONIA 1
372 DYSPNOEA EXERTIONAL 1
373 EMOTIONAL DISTRESS 1
374 EOSINOPHIL COUNT INCREASED 1
375 EOSINOPHILIA 1
376 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1
377 EYE IRRITATION 1
378 FACIAL PARALYSIS 1
379 FLATULENCE 1
380 FLUID INTAKE REDUCED 1
381 FLUID RETENTION 1
382 FOLLICULAR LYMPHOMA 1
383 FOLLICULAR LYMPHOMA STAGE IV 1
384 FORMICATION 1
385 GASTROINTESTINAL ULCER 1
386 GOUT 1
387 GRANULOMA ANNULARE 1
388 HAEMATOCRIT DECREASED 1
389 HAEMOGLOBIN ABNORMAL 1
390 HAEMOLYSIS 1
391 HAEMOPTYSIS 1
392 HAIR TEXTURE ABNORMAL 1
393 HALLUCINATION 1
394 HEAD INJURY 1
395 HEAVY MENSTRUAL BLEEDING 1
396 HEPATITIS 1
397 HEREDITARY ANGIOEDEMA 1
398 HERPES SIMPLEX 1
399 HICCUPS 1
400 HIP FRACTURE 1
401 HYPERKALAEMIA 1
402 HYPERLIPIDAEMIA 1
403 HYPERTHERMIA 1
404 HYPERTONIC BLADDER 1
405 HYPERTRANSAMINASAEMIA 1
406 HYPOCHOLESTEROLAEMIA 1
407 HYPOGLYCAEMIA 1
408 HYPOKINESIA 1
409 HYPOPNOEA 1
410 HYPOTHYROIDISM 1
411 IDIOPATHIC PULMONARY FIBROSIS 1
412 IMMUNE THROMBOCYTOPENIA 1
413 INCREASED APPETITE 1
414 INFUSION SITE DISCOMFORT 1
415 INFUSION SITE EXFOLIATION 1
416 INFUSION SITE HAEMATOMA 1
417 INFUSION SITE PAIN 1
418 INITIAL INSOMNIA 1
419 INJECTION SITE PRURITUS 1
420 INTERCEPTED DRUG ADMINISTRATION ERROR 1
421 INTERSTITIAL LUNG DISEASE 1
422 INTERVERTEBRAL DISC PROTRUSION 1
423 INTESTINAL OBSTRUCTION 1
424 INTESTINAL PERFORATION 1
425 LEUKAEMIA 1
426 LEUKOPENIA 1
427 LIGAMENT SPRAIN 1
428 LIP ERYTHEMA 1
429 LIP SWELLING 1
430 LIPOMA 1
431 LIQUID PRODUCT PHYSICAL ISSUE 1
432 LIVE BIRTH 1
433 LIVER FUNCTION TEST ABNORMAL 1
434 LYMPHADENOPATHY 1
435 LYMPHOCYTE COUNT DECREASED 1
436 MALIGNANT PLEURAL EFFUSION 1
437 MANIA 1
438 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1
439 MEDICAL AID IN DYING 1
440 MEDICAL PROCEDURE 1
441 MENTAL IMPAIRMENT 1
442 METASTASIS 1
443 MIDDLE EAR EFFUSION 1
444 MIDDLE INSOMNIA 1
445 MILIARIA 1
446 MITRAL VALVE CALCIFICATION 1
447 MITRAL VALVE PROLAPSE 1
448 MONOCYTOSIS 1
449 MOUTH ULCERATION 1
450 MOVEMENT DISORDER 1
451 MUSCULOSKELETAL DISCOMFORT 1
452 NAIL DISORDER 1
453 NASAL CONGESTION 1
454 NECK INJURY 1
455 NERVE COMPRESSION 1
456 NEURALGIA 1
457 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1
458 NEUTROPHIL COUNT ABNORMAL 1
459 NEUTROPHIL COUNT INCREASED 1
460 NIGHTMARE 1
461 NON-HODGKIN^S LYMPHOMA 1
462 OCULAR HYPERAEMIA 1
463 OESOPHAGEAL INFECTION 1
464 OPEN ANGLE GLAUCOMA 1
465 OPTIC NERVE INJURY 1
466 ORAL MUCOSAL BLISTERING 1
467 ORAL PRURITUS 1
468 OVERLAP SYNDROME 1
469 OXYGEN SATURATION DECREASED 1
470 PAIN OF SKIN 1
471 PALLOR 1
472 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1
473 PARANEOPLASTIC RASH 1
474 PLATELET DISORDER 1
475 PLEURAL EFFUSION 1
476 PNEUMONIA BACTERIAL 1
477 PNEUMONITIS 1
478 POLLAKIURIA 1
479 POOR QUALITY PRODUCT ADMINISTERED 1
480 POST PROCEDURAL INFECTION 1
481 PRESYNCOPE 1
482 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1
483 PRODUCT ADMINISTRATION ERROR 1
484 PRODUCT COMPLAINT 1
485 PRODUCT CONFUSION 1
486 PRODUCT CONTAINER ISSUE 1
487 PRODUCT DISTRIBUTION ISSUE 1
488 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1
489 PSEUDOMONAS INFECTION 1
490 RASH GENERALISED 1
491 RASH MACULO-PAPULAR 1
492 RASH PAPULAR 1
493 RASH VESICULAR 1
494 RED BLOOD CELL COUNT DECREASED 1
495 RED CELL DISTRIBUTION WIDTH INCREASED 1
496 REHABILITATION THERAPY 1
497 RENAL DISORDER 1
498 RENAL FUNCTION TEST ABNORMAL 1
499 RENAL IMPAIRMENT 1
500 RESPIRATORY FAILURE 1
501 RESPIRATORY TRACT CONGESTION 1
502 RICHTER^S SYNDROME 1
503 ROSAI-DORFMAN SYNDROME 1
504 SARS-COV-2 TEST POSITIVE 1
505 SCAR 1
506 SCRATCH 1
507 SEPSIS 1
508 SINUS DISORDER 1
509 SINUS RHYTHM 1
510 SKIN BURNING SENSATION 1
511 SKIN CANCER 1
512 SKIN IRRITATION 1
513 SKIN TEXTURE ABNORMAL 1
514 STRESS 1
515 SUBCLAVIAN VEIN THROMBOSIS 1
516 TACHYPNOEA 1
517 TASTE DISORDER 1
518 TEMPERATURE INTOLERANCE 1
519 THERAPEUTIC PRODUCT EFFECT DELAYED 1
520 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
521 THERAPY INTERRUPTED 1
522 THYROID MASS 1
523 TOOTHACHE 1
524 TOTAL LUNG CAPACITY INCREASED 1
525 TOXICITY TO VARIOUS AGENTS 1
526 TRICHORRHEXIS 1
527 TRIGEMINAL NEURALGIA 1
528 TUBERCULOSIS 1
529 TUBULOINTERSTITIAL NEPHRITIS 1
530 TUMOUR LYSIS SYNDROME 1
531 ULCER HAEMORRHAGE 1
532 UNDERDOSE 1
533 UPPER MOTOR NEURONE LESION 1
534 UPPER-AIRWAY COUGH SYNDROME 1
535 URINARY RETENTION 1
536 VASCULITIS 1
537 WHITE BLOOD CELL COUNT DECREASED 1
538 WRONG DRUG ADMINISTERED 1